Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 911

1.

Safety and effectiveness of regorafenib in patients with metastatic colorectal cancer in routine clinical practice in the prospective, observational CORRELATE study.

Ducreux M, Petersen LN, Öhler L, Bergamo F, Metges JP, de Groot JW, Wang JY, García Paredes B, Dochy E, Fiala-Buskies S, Cervantes A, O'Connor JM, Falcone A; CORRELATE Investigators.

Eur J Cancer. 2019 Nov 4;123:146-154. doi: 10.1016/j.ejca.2019.09.015. [Epub ahead of print]

2.

Immune biology of glioma associated macrophages and microglia: Functional and therapeutic implications.

Wei J, Chen P, Gupta P, Ott M, Zamler D, Kassab C, Bhat KP, Curran MA, de Groot JF, Heimberger AB.

Neuro Oncol. 2019 Nov 3. pii: noz212. doi: 10.1093/neuonc/noz212. [Epub ahead of print]

PMID:
31679017
3.

Treatment strategies for glioblastoma in older patients: age is just a number.

Youssef M, Ludmir EB, Mandel JJ, Patel AJ, Jalali A, Treiber J, Wu J, McAleer MF, de Groot JF.

J Neurooncol. 2019 Nov;145(2):357-364. doi: 10.1007/s11060-019-03304-x. Epub 2019 Oct 23.

PMID:
31643011
4.

Instruments Measuring Physical Activity in Individuals Who Use a Wheelchair: A Systematic Review of Measurement Properties.

Lankhorst K, Oerbekke M, van den Berg-Emons R, Takken T, de Groot J.

Arch Phys Med Rehabil. 2019 Oct 10. pii: S0003-9993(19)31122-0. doi: 10.1016/j.apmr.2019.09.006. [Epub ahead of print] Review.

PMID:
31606452
5.

Targeted Therapy in Advanced Melanoma With Rare BRAF Mutations.

Menzer C, Menzies AM, Carlino MS, Reijers I, Groen EJ, Eigentler T, de Groot JWB, van der Veldt AAM, Johnson DB, Meiss F, Schlaak M, Schilling B, Westgeest HM, Gutzmer R, Pföhler C, Meier F, Zimmer L, Suijkerbuijk KPM, Haalck T, Thoms KM, Herbschleb K, Leichsenring J, Menzer A, Kopp-Schneider A, Long GV, Kefford R, Enk A, Blank CU, Hassel JC.

J Clin Oncol. 2019 Nov 20;37(33):3142-3151. doi: 10.1200/JCO.19.00489. Epub 2019 Oct 3.

PMID:
31580757
6.

Prolonged Tpeak -Tend interval is a risk factor for sudden cardiac death in adults with congenital heart disease.

Vehmeijer JT, Koyak Z, Vink AS, Budts W, Harris L, Silversides CK, Oechslin EN, Zwinderman AH, Mulder BJM, de Groot JR.

Congenit Heart Dis. 2019 Oct 1. doi: 10.1111/chd.12847. [Epub ahead of print]

PMID:
31573144
7.

PREventive left atrial appenDage resection for the predICtion of fuTure atrial fibrillation: design of the PREDICT AF study.

van den Berg NWE, Neefs J, Berger WR, Boersma LVA, van Boven WJ, van Putte BP, Kaya A, Kawasaki M, Driessen AHG, de Groot JR; PREDICT AF Investigators.

J Cardiovasc Med (Hagerstown). 2019 Nov;20(11):752-761. doi: 10.2459/JCM.0000000000000868.

PMID:
31567634
8.

The path forward for anti-programmed cell death-1 therapy in gliomas.

Majd N, Kamiya-Matsuoka C, de Groot J.

Curr Opin Neurol. 2019 Dec;32(6):864-871. doi: 10.1097/WCO.0000000000000746.

PMID:
31567548
9.

Acetylcholine Delays Atrial Activation to Facilitate Atrial Fibrillation.

Bayer JD, Boukens BJ, Krul SPJ, Roney CH, Driessen AHG, Berger WR, van den Berg NWE, Verkerk AO, Vigmond EJ, Coronel R, de Groot JR.

Front Physiol. 2019 Sep 4;10:1105. doi: 10.3389/fphys.2019.01105. eCollection 2019.

10.

Are we AKT-ually getting closer to making targeted therapy successful in breast cancer brain metastases?

Majd N, Weathers SP, de Groot J.

Neuro Oncol. 2019 Nov 4;21(11):1344-1345. doi: 10.1093/neuonc/noz177. No abstract available.

PMID:
31515554
11.

Diagnostic Accuracy of a Smartphone-Operated, Single-Lead Electrocardiography Device for Detection of Rhythm and Conduction Abnormalities in Primary Care.

Himmelreich JCL, Karregat EPM, Lucassen WAM, van Weert HCPM, de Groot JR, Handoko ML, Nijveldt R, Harskamp RE.

Ann Fam Med. 2019 Sep;17(5):403-411. doi: 10.1370/afm.2438.

12.

The Subtle Signaling Strength of Smells: A Masked Odor Enhances Interpersonal Trust.

van Nieuwenburg D, de Groot JHB, Smeets MAM.

Front Psychol. 2019 Aug 20;10:1890. doi: 10.3389/fpsyg.2019.01890. eCollection 2019.

13.

Middle-aged adults cocontract with arm ADductors during arm ABduction, while young adults do not. Adaptations to preserve pain-free function?

Overbeek CL, Kolk A, de Groot JH, de Witte PB, Gademan MGJ, Nelissen RGHH, Nagels J.

J Electromyogr Kinesiol. 2019 Aug 21;49:102351. doi: 10.1016/j.jelekin.2019.102351. [Epub ahead of print]

PMID:
31473453
14.

Physical activity and sedentary behaviour in children with spina bifida.

Claridge EA, Bloemen MAT, Rook RA, Obeid J, Timmons BW, Takken T, Van Den Berg-Emons RJG, De Groot JF, Gorter JW.

Dev Med Child Neurol. 2019 Dec;61(12):1400-1407. doi: 10.1111/dmcn.14333. Epub 2019 Aug 30.

PMID:
31468507
15.

The risk of not receiving adjuvant chemotherapy after resection of pancreatic ductal adenocarcinoma: a nationwide analysis.

Mackay TM, Smits FJ, Roos D, Bonsing BA, Bosscha K, Busch OR, Creemers GJ, van Dam RM, van Eijck CHJ, Gerhards MF, de Groot JWB, Groot Koerkamp B, Haj Mohammad N, van der Harst E, de Hingh IHJT, Homs MYV, Kazemier G, Liem MSL, de Meijer VE, Molenaar IQ, Nieuwenhuijs VB, van Santvoort HC, van der Schelling GP, Stommel MWJ, Ten Tije AJ, de Vos-Geelen J, Wit F, Wilmink JW, van Laarhoven HWM, Besselink MG; Dutch Pancreatic Cancer Group.

HPB (Oxford). 2019 Aug 19. pii: S1365-182X(19)30610-0. doi: 10.1016/j.hpb.2019.06.019. [Epub ahead of print]

PMID:
31439478
16.

Adverse events associated with encorafenib plus binimetinib in the COLUMBUS study: incidence, course and management.

Gogas HJ, Flaherty KT, Dummer R, Ascierto PA, Arance A, Mandala M, Liszkay G, Garbe C, Schadendorf D, Krajsova I, Gutzmer R, Sileni VC, Dutriaux C, de Groot JWB, Yamazaki N, Loquai C, Gollerkeri A, Pickard MD, Robert C.

Eur J Cancer. 2019 Sep;119:97-106. doi: 10.1016/j.ejca.2019.07.016. Epub 2019 Aug 19.

17.

Determinants of left atrium thrombi in scheduled cardioversion: an ENSURE-AF study analysis.

Merino JL, Lip GYH, Heidbuchel H, Cohen AA, De Caterina R, de Groot JR, Ezekowitz MD, Le Heuzey JY, Themistoclakis S, Jin J, Melino M, Winters SM, Merkely B, Goette A.

Europace. 2019 Nov 1;21(11):1633-1638. doi: 10.1093/europace/euz213.

18.

Should Every Patient With Atrial Fibrillation and a CHA2DS2-VASc Score of 1 Be Anticoagulated? A Systematic Review of 37,030 Patients.

Neefs J, Klamer TA, Krul SPJ, de Groot JR.

Cardiol Rev. 2019 Sep/Oct;27(5):249-255. doi: 10.1097/CRD.0000000000000246.

PMID:
31393287
19.

Guideline compliance for bridging anticoagulation use in vitamin-K antagonist patients; practice variation and factors associated with non-compliance.

Moesker MJ, de Groot JF, Damen NL, Bijsterveld NR, Twisk JWR, Huisman MV, de Bruijne MC, Wagner C.

Thromb J. 2019 Aug 5;17:15. doi: 10.1186/s12959-019-0204-x. eCollection 2019.

20.

Atrial high-rate episodes: prevalence, stroke risk, implications for management, and clinical gaps in evidence.

Bertaglia E, Blank B, Blomström-Lundqvist C, Brandes A, Cabanelas N, Dan GA, Dichtl W, Goette A, de Groot JR, Lubinski A, Marijon E, Merkely B, Mont L, Piorkowski C, Sarkozy A, Sulke N, Vardas P, Velchev V, Wichterle D, Kirchhof P.

Europace. 2019 Oct 1;21(10):1459-1467. doi: 10.1093/europace/euz172.

21.

What if there is no prospective, double blind, randomised trial?

de Groot JR.

Neth Heart J. 2019 Oct;27(10):459-461. doi: 10.1007/s12471-019-01317-9. No abstract available.

22.

Metastatic Uveal Melanoma: Treatment Strategies and Survival-Results from the Dutch Melanoma Treatment Registry.

Jochems A, van der Kooij MK, Fiocco M, Schouwenburg MG, Aarts MJ, van Akkooi AC, van den Berkmortel FWPJ, Blank CU, van den Eertwegh AJM, Franken MG, de Groot JB, Haanen JBAG, Hospers GAP, Koornstra RH, Kruit WHJ, Louwman M, Piersma D, van Rijn RS, Suijkerbuijk KPM, Ten Tije AJ, Vreugdenhil G, Wouters MWJM, van Zeijl MCT, van der Hoeven KJM, Kapiteijn E.

Cancers (Basel). 2019 Jul 18;11(7). pii: E1007. doi: 10.3390/cancers11071007.

23.

How reliable is perioperative anticoagulant management? Determining guideline compliance and practice variation by a retrospective patient record review.

Moesker MJ, de Groot JF, Damen NL, Huisman MV, de Bruijne MC, Wagner C.

BMJ Open. 2019 Jul 17;9(7):e029879. doi: 10.1136/bmjopen-2019-029879.

24.

Characteristics of patients initiated on edoxaban in Europe: baseline data from edoxaban treatment in routine clinical practice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe).

De Caterina R, Kelly P, Monteiro P, Deharo JC, de Asmundis C, López-de-Sá E, Weiss TW, Waltenberger J, Steffel J, de Groot JR, Levy P, Bakhai A, Zierhut W, Laeis P, Kerschnitzki M, Reimitz PE, Kirchhof P; ETNA-AF-Europe investigators.

BMC Cardiovasc Disord. 2019 Jul 12;19(1):165. doi: 10.1186/s12872-019-1144-x.

25.

[Pseudoprogression in immune therapy].

de Boer FJ, Stigt JA, Netters FJS, Koornstra RHT, Tije AJT, de Groot JWB.

Ned Tijdschr Geneeskd. 2019 Jul 5;163. pii: D3247. Dutch.

PMID:
31283128
26.

PREVENTION-ACHD: PRospEctiVE study on implaNTable cardioverter-defibrillator therapy and suddeN cardiac death in Adults with Congenital Heart Disease; Rationale and Design.

Vehmeijer JT, Koyak Z, Zwinderman AH, Harris L, Peinado R, Oechslin EN, Silversides CK, Bouma BJ, Budts W, van Gelder IC, Oliver JM, Mulder BJM, de Groot JR.

Neth Heart J. 2019 Oct;27(10):474-479. doi: 10.1007/s12471-019-1297-3.

27.

Challenges and strategies for successful clinical development of immune checkpoint inhibitors in glioblastoma.

Majd N, de Groot J.

Expert Opin Pharmacother. 2019 Sep;20(13):1609-1624. doi: 10.1080/14656566.2019.1621840. Epub 2019 Jul 2.

PMID:
31264484
28.

Bicistronic Design-Based Continuous and High-Level Membrane Protein Production in Escherichia coli.

Claassens NJ, Finger-Bou M, Scholten B, Muis F, de Groot JJ, de Gier JW, de Vos WM, van der Oost J.

ACS Synth Biol. 2019 Jul 19;8(7):1685-1690. doi: 10.1021/acssynbio.9b00101. Epub 2019 Jul 2.

29.

Playing by the rules.

van der Ree MH, Scholte RA, Postema PG, de Groot JR.

Eur Heart J. 2019 Jun 21;40(24):1900-1902. doi: 10.1093/eurheartj/ehz398. No abstract available.

PMID:
31226209
30.

Letter: When Less is More: Dexamethasone Dosing for Brain Tumors.

Lim-Fat MJ, Bi WL, Lo J, Lee EQ, Ahluwalia MS, Batchelor TT, Chang SM, Chiocca EA, Chukwueke U, Cloughesy TF, Colman H, Deangelis LM, Galanis E, Gilbert MR, De Groot JF, Lassman AB, Liau LM, Mason W, McFaline-Figueroa JR, Mehta MP, Mellinghoff IK, Nabors LB, Nayak L, Reardon DA, Wen PY.

Neurosurgery. 2019 Sep 1;85(3):E607-E608. doi: 10.1093/neuros/nyz186. No abstract available.

PMID:
31215634
31.

Effect of Spironolactone on Atrial Fibrillation in Patients with Heart Failure with Preserved Ejection Fraction: Post-Hoc Analysis of the Randomized, Placebo-Controlled TOPCAT Trial.

Neefs J, van den Berg NWE, Krul SPJ, Boekholdt SM, de Groot JR.

Am J Cardiovasc Drugs. 2019 Jun 19. doi: 10.1007/s40256-019-00353-5. [Epub ahead of print]

PMID:
31214914
32.

Occurrence of Antithrombotic Related Adverse Events in Hospitalized Patients: Incidence and Clinical Context between 2008 and 2016.

Moesker MJ, Schutijser BCFM, de Groot JF, Langelaan M, Spreeuwenberg P, Huisman MV, de Bruijne MC, Wagner C.

J Clin Med. 2019 Jun 12;8(6). pii: E839. doi: 10.3390/jcm8060839.

33.

Sports Participation, Physical Activity, and Health-Related Fitness in Youth With Chronic Diseases or Physical Disabilities: The Health in Adapted Youth Sports Study.

Lankhorst K, Takken T, Zwinkels M, van Gaalen L, Velde ST, Backx F, Verschuren O, Wittink H, de Groot J.

J Strength Cond Res. 2019 Mar 13. doi: 10.1519/JSC.0000000000003098. [Epub ahead of print]

PMID:
31210643
34.

[Immunotherapy for cancer: from medical breakthrough to application in daily practice].

Dekker NRP, Stigt JA, Visser O, Netters FJS, Koornstra RHT, de Groot JWB.

Ned Tijdschr Geneeskd. 2019 May 31;163. pii: D3782. Dutch.

PMID:
31187969
35.

Barriers to Accrual and Enrollment in Brain Tumor Trials.

Lee EQ, Chukwueke UN, Hervey-Jumper SL, de Groot JF, Leone JP, Armstrong TS, Chang SM, Arons D, Oliver K, Verble K, Musella A, Willmarth N, Alexander BM, Bates A, Doherty L, Galanis E, Gaffey S, Halkin T, Friday BE, Fouladi M, Lin NU, Macdonald D, Mehta MP, Penas-Prado M, Vogelbaum MA, Sahebjam S, Sandak D, van den Bent M, Weller M, Reardon DA, Wen PY.

Neuro Oncol. 2019 Jun 7. pii: noz104. doi: 10.1093/neuonc/noz104. [Epub ahead of print]

PMID:
31175826
36.

Association Between Pembrolizumab-related Adverse Events and Treatment Outcome in Advanced Melanoma: Results From the Dutch Expanded Access Program.

Bisschop C, Wind TT, Blank CU, Koornstra RHT, Kapiteijn E, Van den Eertwegh AJM, De Groot JWB, Jalving M, Hospers GAP.

J Immunother. 2019 Jul/Aug;42(6):208-214. doi: 10.1097/CJI.0000000000000271.

PMID:
31145233
37.

Transient ST-segment elevation and coronary flow.

Coronel R, de Groot JR, Piek JJ.

Eur Heart J. 2019 Aug 1;40(29):2463-2464. doi: 10.1093/eurheartj/ehz331. No abstract available.

PMID:
31143929
38.

Additional Diagnostic value of Mini Electrodes in an 8-mm Tip in Cavotricuspid Isthmus Ablation.

Mol D, Berger WR, Khan M, de Ruiter GS, Kimman GP, de Jong JS, de Groot JR.

J Atr Fibrillation. 2018 Oct 31;11(3):2082. doi: 10.4022/jafib.2082. eCollection 2018 Oct-Nov.

39.

Altered Cocontraction Patterns of Humeral Head Depressors in Patients with Subacromial Pain Syndrome: A Cross-sectional Electromyography Analysis.

Overbeek CL, Kolk A, de Groot JH, Visser CPJ, van der Zwaal P, Jens A, Nagels J, Nelissen RGHH.

Clin Orthop Relat Res. 2019 Aug;477(8):1862-1868. doi: 10.1097/CORR.0000000000000745.

PMID:
31107319
40.

Body mass index and body fat distribution and new-onset atrial fibrillation: Substudy of the European Prospective Investigation into Cancer and Nutrition in Norfolk (EPIC-Norfolk) study.

Neefs J, Boekholdt SM, Khaw KT, Luben R, Pfister R, Wareham NJ, Meulendijks ER, Sanders P, de Groot JR.

Nutr Metab Cardiovasc Dis. 2019 Jul;29(7):692-700. doi: 10.1016/j.numecd.2019.03.005. Epub 2019 Mar 15.

PMID:
31079869
41.

Living in two worlds: Becoming and being a doctor among those who identify with "not from an advantaged background".

Conway-Hicks S, de Groot JM.

Curr Probl Pediatr Adolesc Health Care. 2019 Apr;49(4):92-101. doi: 10.1016/j.cppeds.2019.03.006. Epub 2019 May 3.

PMID:
31060911
42.

Driving Difficulties Among Patients with Alzheimer's Disease and Other Neurodegenerative Disorders.

Fuermaier ABM, Piersma D, de Waard D, Davidse RJ, de Groot J, Doumen MJA, Bredewoud RA, Claesen R, Lemstra AW, Scheltens P, Vermeeren A, Ponds R, Verhey F, De Deyn PP, Brouwer WH, Tucha O.

J Alzheimers Dis. 2019;69(4):1019-1030. doi: 10.3233/JAD-181095.

PMID:
31045516
43.

Wheelchair Mobility Confidence Scale for Dutch youth using a manual wheelchair.

Sol ME, Bloemen MAT, Verschuren O, Rushton PW, Visser-Meily JMA, de Groot JF.

Disabil Rehabil Assist Technol. 2019 Apr 23:1-8. doi: 10.1080/17483107.2019.1604832. [Epub ahead of print]

PMID:
31012747
44.

Response to Beaudreuil and Orcel regarding: "Increased co-contraction of arm adductors is associated with a favorable course in subacromial pain syndrome".

Overbeek CL, Kolk A, Nagels J, de Witte PB, van der Zwaal P, Visser CPJ, Fiocco M, Nelissen RGHH, de Groot JH.

J Shoulder Elbow Surg. 2019 Jun;28(6):e195-e196. doi: 10.1016/j.jse.2018.12.021. Epub 2019 Apr 12. No abstract available.

PMID:
30987791
45.

Clinical trial participation of patients with glioblastoma at The University of Texas MD Anderson Cancer Center.

Harrison RA, Anderson MD, Cachia D, Kamiya-Matsuoka C, Weathers SS, O'Brien BJ, Penas-Prado M, Yung WKA, Wu J, Yuan Y, de Groot JF.

Eur J Cancer. 2019 May;112:83-93. doi: 10.1016/j.ejca.2019.02.007. Epub 2019 Apr 2.

PMID:
30951926
46.

Utrecht Pediatric Wheelchair Mobility Skills Test: Reliability, Validity, and Responsiveness in Youths Using a Manual Wheelchair.

Sol ME, de Groot JF, Zwinkels M, Visser-Meily JMA, Kruitwagen CLJJ, Verschuren O.

Phys Ther. 2019 Aug 1;99(8):1098-1106. doi: 10.1093/ptj/pzz061.

PMID:
30939199
47.

Prospective Clinical Sequencing of Adult Glioma.

Zheng S, Alfaro-Munoz K, Wei W, Wang X, Wang F, Eterovic AK, Shaw KRM, Meric-Bernstam F, Fuller GN, Chen K, Verhaak RG, Mills GB, Yung WKA, Weathers SP, de Groot JF.

Mol Cancer Ther. 2019 May;18(5):991-1000. doi: 10.1158/1535-7163.MCT-18-1122. Epub 2019 Mar 29.

PMID:
30926639
48.

Commentary on "Cardiopulmonary Exercise Test Using Arm Ergometry in Children With Spina Bifida: A Prediction Model for O2peak.

de Groot JF, Sol M.

Pediatr Phys Ther. 2019 Apr;31(2):191. doi: 10.1097/PEP.0000000000000600. No abstract available.

PMID:
30907837
49.

Additional Ganglion Plexus Ablation During Thoracoscopic Surgical Ablation of Advanced Atrial Fibrillation: Intermediate Follow-Up of the AFACT Study.

Berger WR, Neefs J, van den Berg NWE, Krul SPJ, van Praag EM, Piersma FR, de Jong JSSG, van Boven WP, Driessen AHG, de Groot JR.

JACC Clin Electrophysiol. 2019 Mar;5(3):343-353. doi: 10.1016/j.jacep.2018.10.008. Epub 2018 Nov 28.

50.

Examining Causes and Prevention Strategies of Adverse Events in Deceased Hospital Patients: A Retrospective Patient Record Review Study in the Netherlands.

Smits M, Langelaan M, de Groot J, Wagner C.

J Patient Saf. 2019 Mar 20. doi: 10.1097/PTS.0000000000000586. [Epub ahead of print]

PMID:
30896559

Supplemental Content

Loading ...
Support Center